ArticleNature communications2020
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer.
Elaine Sanij et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
105 papers cite itlatest 60 shown
this papercites it